4002 logo

Mouwasat Medical Services Company Stock Price

SASE:4002 Community·ر.س13.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 72 Fair Values set on narratives written by author

4002 Share Price Performance

ر.س65.35
-5.75 (-8.09%)
ر.س98.60
Fair Value
ر.س65.35
-5.75 (-8.09%)
33.7% undervalued intrinsic discount
ر.س98.60
Fair Value
Price ر.س65.35
Valtersa ر.س98.60

4002 Community Narratives

Fair Value
·
Fair Value ر.س98.6 33.7% undervalued intrinsic discount

Mouwasat Medical Services Will Achieve a 25% Profit Margin in Just 3 Years

4users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
ر.س98.6
33.7% undervalued intrinsic discount
Fair Value
Set with the author's own calculation method

Trending Discussion

No trending discussion available.

Updated Narratives

4002 logo

Mouwasat Medical Services Will Achieve a 25% Profit Margin in Just 3 Years

Fair Value: ر.س98.6 33.7% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record with flawless balance sheet and pays a dividend.

0 Risks
5 Rewards

Mouwasat Medical Services Company Key Details

ر.س3.4b

Revenue

ر.س2.0b

Cost of Revenue

ر.س1.4b

Gross Profit

ر.س516.4m

Other Expenses

ر.س850.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
4.25
40.53%
25.22%
27.0%
View Full Analysis

About 4002

Founded
1974
Employees
n/a
CEO
Nasser Sultan Al-Subaie
WebsiteView website
www.mouwasat.com

Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services and specialized centers, including eye, obesity, cardiology, diabetic, robotic, fertility, rehabilitation, long term care, stroke, and skincare center. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services. In addition, the company is involved in construction and operation of hospitals, dispensaries, and special clinics; general construction of non-residential buildings, including schools, hospitals, and hotels; demolition of buildings; purchase, sale, and division of land and real estate; off-plan sales activities; operation of colleges and university institutes; and medical operation of hospitals. Further, it wholesales medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.

Recent 4002 News & Updates

Analysis Article Aug 07

Analysts Are Updating Their Mouwasat Medical Services Company (TADAWUL:4002) Estimates After Its Second-Quarter Results

Investors in Mouwasat Medical Services Company ( TADAWUL:4002 ) had a good week, as its shares rose 2.1% to close at...
New Narrative Jun 10

Mouwasat Medical Services Will Achieve a 25% Profit Margin in Just 3 Years

Overview P/E: 15.67 RSI: 42 (Reflects the stock approaching relatively oversold areas due to the recent decline). Dividend Yield: 3.28% What is their moat: The company's economic moat consists of two main barriers: the massive capital cost of infrastructure (hospitals costing hundreds of millions) which prevents new competitors from easily entering the market, and the "network advantage" with its deep integration with major insurance companies, alongside regulatory complexities and Ministry of Health licensing.

Recent updates

No updates